Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

PHASE2CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

November 13, 2023

Study Completion Date

October 12, 2024

Conditions

Acute Bacterial Conjunctivitis

Interventions

DRUG

IVIEW-1201

Four times per day for day 1-2 and three times per day for day 3-7

DRUG

Ofloxacin Eye Drops

Four times per day for day 1-2 and three times per day for day 3-7

Trial Locations (1)

Eye Hospital of Shandong First Medical University, Jinan